-
2
-
-
0034027095
-
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: An effective regimen with low procedure-related toxicity
-
Cull GM, Haynes AP, Byrne JL et al. Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity. Br J Haematol 2000; 108: 754-760.
-
(2000)
Br. J. Haematol.
, vol.108
, pp. 754-760
-
-
Cull, G.M.1
Haynes, A.P.2
Byrne, J.L.3
-
3
-
-
0038578245
-
Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: Relevance for early adoptive immunotherapy and infectious complications
-
Morris EC, Rebello P, Thomson KJ et al. Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications. Blood 2003; 102: 404-406.
-
(2003)
Blood
, vol.102
, pp. 404-406
-
-
Morris, E.C.1
Rebello, P.2
Thomson, K.J.3
-
4
-
-
0035555519
-
Pharmacokinetics of CAMPATH-1H in BMT patients
-
Rebello P, Cwynarski K, Varughese M et al. Pharmacokinetics of CAMPATH-1H in BMT patients. Cytotherapy 2001; 3: 261-267.
-
(2001)
Cytotherapy
, vol.3
, pp. 261-267
-
-
Rebello, P.1
Cwynarski, K.2
Varughese, M.3
-
5
-
-
0020591822
-
Removal of T cells from bone marrow for transplantation: A monoclonal antilymphocyte antibody that fixes human complement
-
Hale G, Bright S, Chumbley G et al. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood 1983; 62: 873-882.
-
(1983)
Blood
, vol.62
, pp. 873-882
-
-
Hale, G.1
Bright, S.2
Chumbley, G.3
-
6
-
-
0027240401
-
Effect of Campath-1H antibody on human hematopoietic progenitors in vitro
-
Gilleece MH, Dexter TM. Effect of Campath-1H antibody on human hematopoietic progenitors in vitro. Blood 1993; 82: 807-812.
-
(1993)
Blood
, vol.82
, pp. 807-812
-
-
Gilleece, M.H.1
Dexter, T.M.2
-
7
-
-
0032005642
-
Levels of expression of CD52 in normal and leukemic B and T cells: Correlation with in vivo therapeutic responses to Campath-1H
-
Ginaldi L, De Martinis M, Matutes E et al. Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H. Leak Res 1998; 22: 185-191.
-
(1998)
Leak. Res.
, vol.22
, pp. 185-191
-
-
Ginaldi, L.1
De Martinis, M.2
Matutes, E.3
-
9
-
-
0033836378
-
Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria
-
Richards SJ, Rawstron AC, Hillmen P. Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry 2000; 42: 223-233.
-
(2000)
Cytometry
, vol.42
, pp. 223-233
-
-
Richards, S.J.1
Rawstron, A.C.2
Hillmen, P.3
-
10
-
-
0029670929
-
Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment
-
Brett SJ, Baxter G, Cooper H et al. Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment. Int Immunol 1996; 8: 325-334.
-
(1996)
Int. Immunol.
, vol.8
, pp. 325-334
-
-
Brett, S.J.1
Baxter, G.2
Cooper, H.3
-
11
-
-
0032736327
-
The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment
-
Rawstron AC, Rollinson SJ, Richards S et al. The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment. Br J Haematol 1999; 107: 148-153.
-
(1999)
Br. J. Haematol.
, vol.107
, pp. 148-153
-
-
Rawstron, A.C.1
Rollinson, S.J.2
Richards, S.3
-
12
-
-
0028978684
-
Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma
-
Hertenstein B, Wagner B, Bunjes D et al. Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma. Blood 1995; 86: 1487-1492.
-
(1995)
Blood
, vol.86
, pp. 1487-1492
-
-
Hertenstein, B.1
Wagner, B.2
Bunjes, D.3
-
13
-
-
0031022899
-
Clonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52)
-
Osterborg A, Werner A, Halapi E et al. Clonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52). Eur J Haematol 1997; 58: 5-13.
-
(1997)
Eur. J. Haematol.
, vol.58
, pp. 5-13
-
-
Osterborg, A.1
Werner, A.2
Halapi, E.3
-
14
-
-
0036270372
-
Paroxysmal nocturnal haemoglobinuria: Nature's gene therapy?
-
Johnson RJ, Hillmen P. Paroxysmal nocturnal haemoglobinuria: nature's gene therapy? Mol Pathol 2002; 55: 145-152.
-
(2002)
Mol. Pathol.
, vol.55
, pp. 145-152
-
-
Johnson, R.J.1
Hillmen, P.2
-
15
-
-
0033840555
-
Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size
-
Piedras J, Lopez-Karpovitch X. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size. Cytometry 2000; 42: 234-238.
-
(2000)
Cytometry
, vol.42
, pp. 234-238
-
-
Piedras, J.1
Lopez-Karpovitch, X.2
-
16
-
-
0032170054
-
Lymphocyte subset analysis and glycosylphosphatidylinositol phenotype in patients with paroxysmal nocturnal hemoglobinuria
-
Richards SJ, Norfolk DR, Swirsky DM, Hillmen P. Lymphocyte subset analysis and glycosylphosphatidylinositol phenotype in patients with paroxysmal nocturnal hemoglobinuria. Blood 1998; 92: 1799-1806.
-
(1998)
Blood
, vol.92
, pp. 1799-1806
-
-
Richards, S.J.1
Norfolk, D.R.2
Swirsky, D.M.3
Hillmen, P.4
-
17
-
-
0029619212
-
Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria
-
Tseng JE, Hall SE, Howard TA, Ware RE. Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria. Am J Hematol 1995; 50: 244-253.
-
(1995)
Am. J. Hematol.
, vol.50
, pp. 244-253
-
-
Tseng, J.E.1
Hall, S.E.2
Howard, T.A.3
Ware, R.E.4
-
18
-
-
0032878539
-
Analysis of T cells in paroxysmal nocturnal hemoglobinuria provides direct evidence that thymic T-cell production declines with age
-
Richards SJ, Morgan GJ, Hillmen P. Analysis of T cells in paroxysmal nocturnal hemoglobinuria provides direct evidence that thymic T-cell production declines with age. Blood 1999; 94: 2790-2799.
-
(1999)
Blood
, vol.94
, pp. 2790-2799
-
-
Richards, S.J.1
Morgan, G.J.2
Hillmen, P.3
-
19
-
-
0023691376
-
Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies
-
Bindon CI, Hale G, Waldmann H. Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies. Eur J Immunol 1988; 18: 1507-1514.
-
(1988)
Eur. J. Immunol.
, vol.18
, pp. 1507-1514
-
-
Bindon, C.I.1
Hale, G.2
Waldmann, H.3
-
20
-
-
10544223274
-
Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion
-
Cornish JM, Pamphilon DH, Potter MN et al. Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion. Bone Marrow Transplant 1996; 18 (Suppl 2): 31-35.
-
(1996)
Bone Marrow Transplant.
, vol.18
, Issue.SUPPL. 2
, pp. 31-35
-
-
Cornish, J.M.1
Pamphilon, D.H.2
Potter, M.N.3
-
21
-
-
9444257631
-
Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission
-
Oakhill A, Pamphilon DH, Potter MN et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 1996; 94: 574-578.
-
(1996)
Br. J. Haematol.
, vol.94
, pp. 574-578
-
-
Oakhill, A.1
Pamphilon, D.H.2
Potter, M.N.3
-
22
-
-
0842345615
-
Influence of cytomegalovirus (CMV) scro-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: A comparison between two T-cell depletion regimens
-
Chakrabarti S, Milligan DW, Brown J et al. Influence of cytomegalovirus (CMV) scro-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens. Bone Marrow Transplant 2004; 33: 197-204.
-
(2004)
Bone Marrow Transplant.
, vol.33
, pp. 197-204
-
-
Chakrabarti, S.1
Milligan, D.W.2
Brown, J.3
-
23
-
-
0030669663
-
Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation
-
Hancock JP, Burgess MF, Goulden NJ et al. Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation. Br J Haematol 1997; 99: 403-409.
-
(1997)
Br. J. Haematol.
, vol.99
, pp. 403-409
-
-
Hancock, J.P.1
Burgess, M.F.2
Goulden, N.J.3
-
24
-
-
0037262169
-
Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR
-
Hancock JP, Goulden NJ, Oakhill A, Steward CG. Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR. Leukemia 2003; 17: 247-251.
-
(2003)
Leukemia
, vol.17
, pp. 247-251
-
-
Hancock, J.P.1
Goulden, N.J.2
Oakhill, A.3
Steward, C.G.4
-
25
-
-
0028131848
-
Persistence of affected T lymphocytes in long-term clinical remission in paroxysmal nocturnal hemoglobinuria
-
Nakakuma H, Nagakura S, Kawaguchi T et al. Persistence of affected T lymphocytes in long-term clinical remission in paroxysmal nocturnal hemoglobinuria. Blood 1994; 84: 3925-3928.
-
(1994)
Blood
, vol.84
, pp. 3925-3928
-
-
Nakakuma, H.1
Nagakura, S.2
Kawaguchi, T.3
-
26
-
-
0035655579
-
Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes
-
Ware RE, Pickens CV, DeCastro CM, Howard TA. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes. Exp Hematol 2001; 29: 1403-1409.
-
(2001)
Exp. Hematol.
, vol.29
, pp. 1403-1409
-
-
Ware, R.E.1
Pickens, C.V.2
DeCastro, C.M.3
Howard, T.A.4
-
27
-
-
0035691895
-
Immunophenotype changes and loss of CD52 expression in two patients with relapsed T-cell prolymphocytic leukaemia
-
Tuset E, Matutes E, Brito-Babapulle V et al. Immunophenotype changes and loss of CD52 expression in two patients with relapsed T-cell prolymphocytic leukaemia. Leuk Lymphoma 2001; 42: 1379-1383.
-
(2001)
Leuk. Lymphoma
, vol.42
, pp. 1379-1383
-
-
Tuset, E.1
Matutes, E.2
Brito-Babapulle, V.3
-
28
-
-
0022629899
-
Leukaemic relapse associated with phenotypic change after CAMPATH-1 purged autologous bone marrow transplantation
-
Poynton CH, Shaw PJ, Barrett AJ. Leukaemic relapse associated with phenotypic change after CAMPATH-1 purged autologous bone marrow transplantation. Lancet 1986; 1: 162.
-
(1986)
Lancet
, vol.1
, pp. 162
-
-
Poynton, C.H.1
Shaw, P.J.2
Barrett, A.J.3
-
29
-
-
0036099863
-
Phenotypic transformation of CD52(pos) to CD52(neg) leukemic T cells as a mechanism for resistance to CAMPATH-1H
-
Birhiray RE, Shaw G, Guldan S et al. Phenotypic transformation of CD52(pos) to CD52(neg) leukemic T cells as a mechanism for resistance to CAMPATH-1H. Leukemia 2002; 16: 861-864.
-
(2002)
Leukemia
, vol.16
, pp. 861-864
-
-
Birhiray, R.E.1
Shaw, G.2
Guldan, S.3
-
30
-
-
0030906149
-
Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism
-
Taylor VC, Sims M, Brett S, Field MC. Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism. Biochem J 1997; 322: 919-925.
-
(1997)
Biochem. J.
, vol.322
, pp. 919-925
-
-
Taylor, V.C.1
Sims, M.2
Brett, S.3
Field, M.C.4
-
31
-
-
0029666221
-
Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H
-
Brett S, Baxter G, Cooper H et al. Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H. Immunology 1996; 88: 13-19.
-
(1996)
Immunology
, vol.88
, pp. 13-19
-
-
Brett, S.1
Baxter, G.2
Cooper, H.3
-
32
-
-
0027170545
-
Graft rejection by a population of primed CDw52-host T cells after in vivo/ex vivo T-depleted bone marrow transplantation
-
Bunjes D, Theobald M, Wiesneth M et al. Graft rejection by a population of primed CDw52-host T cells after in vivo/ex vivo T-depleted bone marrow transplantation. Bone Marrow Transplant 1993; 12: 209-215.
-
(1993)
Bone Marrow Transplant.
, vol.12
, pp. 209-215
-
-
Bunjes, D.1
Theobald, M.2
Wiesneth, M.3
-
33
-
-
0037097836
-
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: Potential role of Campath-1H in delaying immune reconstitution
-
Chakrabarti S, Mackinnon S, Chopra R et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 2002; 99: 4357-4363.
-
(2002)
Blood
, vol.99
, pp. 4357-4363
-
-
Chakrabarti, S.1
Mackinnon, S.2
Chopra, R.3
|